Literature DB >> 1880546

Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain.

D L Martin1, S B Martin, S J Wu, N Espina.   

Abstract

The apoenzyme of glutamate decarboxylase [enzyme without bound cofactor, pyridoxal 5'-phosphate (pyridoxal-P)] serves as a reservoir of inactive glutamate decarboxylase (GAD) that can be activated when additional GABA synthesis is required. We have investigated which of two molecular forms of GAD is present as apoenzyme in synaptosomes and in cortex, caudate nucleus, hippocampus, and cerebellum of rat brain. Endogenous glutamate apodecarboxylase (apoGAD) was labeled by incubating extracts of synaptosomes or punches of each region with 32P-pyridoxal-P, followed by reduction with NaBH4, to link covalently the 32P-pyridoxal-P to GAD. Proteins were separated by SDS-PAGE. Punches from all four brain regions and forebrain synaptosomes contained two forms of GAD with apparent Mrs of 63 and 65 kDa as identified by immunoblotting with four antiGAD sera. Punches and synaptosomes contained a major 32P-pyridoxal-P-labeled band with an apparent Mr of 63 kDa that was stained on immunoblots by the antiGAD serum 1440 and the monoclonal antibody GAD-6, and a minor labeled band at 65 kDa that was stained by the 1440, 6799, and K2 antisera. Synaptosomes contained remarkably few other strongly labeled proteins, but punches contained several other labeled bands. Three additional lines of evidence indicate that the labeled 63-kDa protein is apoGAD: (1) it was purified by immunoaffinity chromatography with the GAD-1 monoclonal antibody; (2) it yielded one major labeled peptide when digested with chymotrypsin, and that peptide appeared identical in peptide-mapping experiments to the labeled active-site peptide isolated from chromatographically prepared rat brain GAD; and (3) its labeling was selectively blocked by 4-deoxypyridoxine 5'-phosphate, a competitive inhibitor of the binding of pyridoxal-P to GAD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880546      PMCID: PMC6575242     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

Review 1.  Molecular analysis of developmental plasticity in neocortex.

Authors:  E Nedivi
Journal:  J Neurobiol       Date:  1999-10

2.  Reduced glutamate decarboxylase 65 protein within primary auditory cortex inhibitory boutons in schizophrenia.

Authors:  Caitlin E Moyer; Kristen M Delevich; Kenneth N Fish; Josephine K Asafu-Adjei; Allan R Sampson; Karl-Anton Dorph-Petersen; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2012-05-23       Impact factor: 13.382

3.  Local GABA circuit control of experience-dependent plasticity in developing visual cortex.

Authors:  T K Hensch; M Fagiolini; N Mataga; M P Stryker; S Baekkeskov; S F Kash
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

4.  Structure and alternative promoters of the mouse glutamic acid decarboxylase 67 gene.

Authors:  Y Yanagawa; T Kobayashi; T Kamei; K Ishii; M Nishijima; A Takaku; S Tamura
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 5.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

6.  Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

Authors:  S F Kash; L H Tecott; C Hodge; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Convulsions and inhibition of glutamate decarboxylase by pyridoxal phosphate-gamma-glutamyl hydrazone in the developing rat.

Authors:  L Massieu; A Rivera; R Tapia
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

8.  Assignment of the rat genes coding for dopa decarboxylase (DDC) and glutamic acid decarboxylases (GAD1 and GAD2).

Authors:  C Vassort; M Rivière; G Bruneau; F Gros; J Thibault; G Levan; J Szpirer; C Szpirer
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

9.  Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Authors:  Pedro Barroso-Chinea; Erwan Bezard
Journal:  Front Neuroanat       Date:  2010-09-14       Impact factor: 3.856

10.  Neurochemical effects of theta burst stimulation as assessed by magnetic resonance spectroscopy.

Authors:  C J Stagg; M Wylezinska; P M Matthews; H Johansen-Berg; P Jezzard; J C Rothwell; S Bestmann
Journal:  J Neurophysiol       Date:  2009-04-01       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.